KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 85 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $765,000 | -49.9% | 85,768 | -25.6% | 0.00% | -50.0% |
| Q4 2015 | $1,528,000 | +9.4% | 115,273 | -13.1% | 0.00% | 0.0% |
| Q3 2015 | $1,397,000 | -63.0% | 132,621 | -4.4% | 0.00% | -55.6% |
| Q2 2015 | $3,775,000 | -5.7% | 138,706 | +6.1% | 0.01% | 0.0% |
| Q1 2015 | $4,002,000 | -43.5% | 130,760 | -30.9% | 0.01% | -50.0% |
| Q4 2014 | $7,083,000 | +138.1% | 189,258 | +122.3% | 0.02% | +157.1% |
| Q3 2014 | $2,975,000 | -29.0% | 85,143 | -5.5% | 0.01% | -36.4% |
| Q2 2014 | $4,193,000 | +85.1% | 90,077 | +22.8% | 0.01% | +83.3% |
| Q1 2014 | $2,265,000 | – | 73,329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |